Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9295903 | 0.98 | APP (0.42) | APPPAOXPTGS1PDE4ALMNA | |
| SCHEMBL4022137 | 0.93 | APP (0.42) | APPPAOXPTGS1PDE4ALMNA | |
| SCHEMBL98490 | 0.91 | ALDH1A1 (0.47) | APPPTGS1LMNACYP2C19BLM | |
| SCHEMBL27723374 | 0.91 | APP (0.38) | APPPAOXPTGS1PDE4ALMNA | |
| SCHEMBL4352917 | 0.91 | PAOX (0.48) | APPPAOXMAPK1KDM4EUSP2 | |
| SCHEMBL4018698 | 0.91 | PAOX (0.42) | APPPAOXHRH3RAD52 | |
| SCHEMBL4016878 | 0.91 | PAOX (0.42) | APPPAOXHRH3RAD52 | |
| SCHEMBL4018181 | 0.91 | PAOX (0.42) | APPPAOXHRH3RAD52 | |
| SCHEMBL4020401 | 0.91 | PAOX (0.42) | APPPAOXHRH3RAD52 | |
| SCHEMBL4014999 | 0.91 | PAOX (0.42) | APPPAOXHRH3RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569620-A | Polymerized monomer, solid electrolyte, preparation method of polymerized monomer, lithium ion battery and electric equipment | 深圳市贝特瑞新能源技术研究院有限公司 | 2025-03-07 | — | — | CN | claimed |
| EP-3856748-B1 | METAL-ORGANIC FRAMEWORK PHASE AND CRYSTALLITE SHAPE CONTROL | UNIV CALIFORNIA (US) | 2024-03-06 | — | — | EP | claimed |
| CN-112771056-B | Metal organic framework phase and crystallite shape control | 加利福尼亚大学董事会 | 2024-02-23 | — | — | CN | claimed |
| US-11850294-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT | 2022-03-17 | — | — | US | claimed |
| US-4324858-A | Stabilization of cholinesterase, detector kit using stabilized cholinesterase, and methods of making and using the same | MIDWEST RESEARCH INSTITUTE (US) | 1982-04-13 | — | — | US | claimed |
| US-20260117285-A1 | COMPOSITIONS AND METHODS FOR IMPROVING LIBRARY ENRICHMENT | ILLUMINA INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4683613-A1 | METHOD FOR PREPARING A STERILE HYDROGEL COMPRISING A CROSS-LINKED OR NON-CROSSLINKED POLYSACCHARIDE OR A MIXTURE THEREOF | Teoxane SA (CH) | 2026-01-28 | — | — | EP | disclosed |
| US-12435362-B2 | Compositions and methods for improving library enrichment | ILLUMINA, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| WO-2025132633-A1 | METHOD FOR CROSSLINKING POLYSACCHARIDE HYDROGELS BY NATIVE CHEMICAL LIGATION, HYDROGELS OBTAINED BY THIS METHOD, AND USES THEREOF | Teoxane SA (CH) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025125597-A1 | POLYSACCHARIDE-BASED HYDROGEL COMPRISING SILICON | Teoxane SA (CH) | 2025-06-19 | — | — | WO | disclosed |
| CN-112955568-B | Compositions and methods for improving library enrichment | ILLUMINA公司 | 2025-05-16 | — | — | CN | disclosed |
| EP-3673039-B1 | PRODUCTION OF BREWER'S WORT HAVING INCREASED FERMENTABLE SUGARS | INT N&H DENMARK APS (DK) | 2025-03-19 | — | — | EP | disclosed |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-03-03 | — | — | US | disclosed |
| US-6466421-B1 | Solid electrolytic capacitor and method for producing the same | SHOWA DENKO K.K. (JP) | 2002-10-15 | — | — | US | disclosed |
| US-6344966-B1 | ELECTRICALLY CONDUCTING POLYMER LAYER CONTAINS AS A DOPANT AN ANION OF(1) ALKOXY-SUBSTITUTED NAPHTHALENESULFONATE, (2) A HETEROCYCLIC SULFONATE, OR (3) AN ANION OF AN ALIPHATIC POLYCYCLIC COMPOUND | SHOWA DENKO K.K. (JP) | 2002-02-05 | — | — | US | disclosed |
| US-6281224-B1 | BENZALKONIUM CHLORIDE EFFECTIVE AS A PRESERVATIVE, AND TROMETHAMINE EFFECTIVE TO KEEP THE SOLUTION STABLE AND CLEAR AND LOWERS EYE IRRITATION | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-08-28 | — | — | US | disclosed |
| EP-1085540-A1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PREPARING THE SAME | Showa Denko K K (JP) | 2001-03-21 | — | — | EP | disclosed |
| EP-0824916-A1 | PRANOPROFEN EYEDROPS CONTAINING ORGANIC AMINE | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-4324858-A | Stabilization of cholinesterase, detector kit using stabilized cholinesterase, and methods of making and using the same | MIDWEST RESEARCH INSTITUTE (US) | 1982-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11850294-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | APP 843/4885PAOX 1390/4885PTGS1 3812/4885 |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | APP 1/4885PAOX 3259/4885PTGS1 4215/4885 |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | CHMP4B, LIPA, APOB | APP 843/4885PAOX 1390/4885PTGS1 3812/4885 |
| US-20260117285-A1 | COMPOSITIONS AND METHODS FOR IMPROVING LIBRARY ENRICHMENT | TTI1, MBNL1, UPF1 | APP 2689/4885PAOX 4236/4885PTGS1 4706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.